DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 77 filers reported holding DIPLOMAT PHARMACY INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,236,000 | +105.3% | 156,249 | +46.7% | 0.01% | +116.7% |
| Q2 2017 | $1,576,000 | +228.3% | 106,500 | +253.5% | 0.01% | +200.0% |
| Q1 2017 | $480,000 | +16.8% | 30,124 | -7.7% | 0.00% | 0.0% |
| Q4 2016 | $411,000 | -51.0% | 32,630 | +8.9% | 0.00% | -50.0% |
| Q3 2016 | $839,000 | -59.9% | 29,969 | -49.9% | 0.00% | -55.6% |
| Q2 2016 | $2,094,000 | +32.0% | 59,815 | +4.1% | 0.01% | +28.6% |
| Q1 2016 | $1,586,000 | -38.4% | 57,467 | -23.6% | 0.01% | -36.4% |
| Q4 2015 | $2,573,000 | +39.2% | 75,201 | +16.8% | 0.01% | +37.5% |
| Q3 2015 | $1,849,000 | -15.1% | 64,366 | +32.2% | 0.01% | -11.1% |
| Q2 2015 | $2,179,000 | +69.2% | 48,686 | +30.7% | 0.01% | +80.0% |
| Q1 2015 | $1,288,000 | +124.8% | 37,244 | +78.0% | 0.01% | +150.0% |
| Q4 2014 | $573,000 | – | 20,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |